Recent advances in molecular biology techniques have provided powerful tools for discovery of novel genes relevant to both biological and pathological processes. mRNA differential display is an emerging technique for novel gene discovery and it has been successfully applied to many physiological and pathological conditions including normal development, cell differentiation, cancer, cardiovascular disease, inflammation and CNS disorders. In the present work, we briefly illustrate the critical procedure and highlight most recent technical improvements and modifications of this technology. Based upon the successful applications of this technique in cardiovascular research, it may provide a valuable and powerful investigational tool for the identification of novel therapeutic targets in cardiovascular diseases. q 1997 Elsevier Science B.V.
Introduction
Differential gene expression is essential for normal development and pathological processes. Therefore, discovery of differentially expressed genes is critical for the understanding of the molecular mechanisms involved in normal and pathological states, as well as providing new insights for discovery of novel molecular targets for pharmacological manipulation and gene therapy. A number of techniques including subtractive library screening, differential hybridization, representational difference analysis Ž . RDA , mRNA differential display, serial analysis of gene Ž . expression SAGE and electronic subtraction have been developed for novel gene discovery to date. Subtractive library screening and differential hybridization are convenw x tional methods 1 for the identification of molecules that differ in abundance between two pools of molecules. RDA w x w x 2,3 and mRNA differential display 4 are polymerase Ž . q1 610 270-4114; e-mail: Giora_Z_Feuerstein @SBPHRD.COM@INET Ž . chain reaction PCR -based techniques and are sufficiently sensitive for the detection of differentially expressed genes. SAGE is a technique that allows a rapid and detailed analysis of thousands of small expressed sequence tags Ž . w x ESTs 5,6 . Electronic subtraction is the method comparing ESTs from experimental and control cDNA libraries w x 7-9 , that also facilitates the identification of the abundant messages since the ESTs from a particular library only represent a small fraction of the total number of differentially expressed genes. Table 1 summarizes some basic features of these techniques for their utilization in novel gene discovery. In the last decade or so, these various techniques have been widely used to identify differentially w x expressed genes in many biological systems 10 . In particular, the mRNA differential display methodology has been adopted by a large number of laboratories as an important tool being applied for both in vitro and in vivo systems w x 11 . Detailed protocols for mRNA differential display w x have been described previously 12,13 . In the present article, we briefly outline the critical procedure of the mRNA differential display technique and its technical improvements and modifications, and summarize its suc- cessful applications for the discovery of novel genes in normal and pathological functions of the cardiovascular system.
Critical procedure of mRNA differential display and its technical improvements and modifications
An overall strategic approach using mRNA differential display for novel gene discovery is outlined in Fig. 1 . The critical technical procedure of mRNA differential display is described briefly below, relative merits, disadvantages, and the improvement and modifications of this technique are discussed along with the text. Table 2 summarizes some of the important modifications on mRNA differential display. 
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The method of mRNA differential display consists of Ž . Ž . two basic steps 
Ž .
MsG, A, C and N s G, A, T, or C, and 2 PCR Ž amplification of cDNA fragments using arbitrary up-. Ž . stream primers and anchored downstream primers. For Ž the RT reaction, total cellular RNA usually DNase-treated to eliminate the possibility of genomic DNA contamina-. tion is reverse-transcribed to yield the first strand cDNA primed with T MN oligonucleotides. This RT reaction 12 Ž . enables all the mRNA species having a poly A tail to be reverse-transcribed. Typically, this reverse transcription reaction is divided into 4 subgroups each using a different T MN primer with G, A, T or C at the last base of the 12 3 X -end. Because a large number of mRNA species are present in a cell, the division of subgroups for the RT allows a portion of the mRNA species to be displayed, which will increase the resolution of cDNA species after w x amplification 4 .
Amplification of all the cDNAs is carried out using an upstream arbitrary primer and a downstream anchored Ž . primer identical to the one used for the RT in the Ž 35 33 presence of a radioactive nucleotide S-a-dATP or P-. a-dATP . The upstream primer has been optimized to 10 bases in length composed of approximately 50% of G or C w x base contents 4 . In addition, a relatively low annealing Ž . temperature 428C is applied in the PCR so that the number of the amplified mRNA species is maximized. Using these conditions of amplification, it has been esti- mated that at least 30-40 upstream primers in combination with the downstream primers will be necessary to amplify w x every mRNA species present in a given cell 25 .
The amplified cDNA fragments are resolved by electrophoresis and subjected to autoradiographic analysis. By taking advantage of mRNA differential display, multiple samples can be amplified and compared in parallel. As such, differences in gene expression, either up-or downregulated, can be identified in specific experimental or pathological conditions or along temporal expression pat-Ž . terns Fig. 3A . For example, the differential display analysis was carried out using cellular RNAs isolated from LPS-stimulated and unstimulated rat carotid artery using a Ž . resolved by electrophoresis Fig. 3B . Several bands were noted for their differential expression in response to LPS Ž stimulation, and one band indicated with an arrowhead in . Fig. 3B was identified for its differential regulation in the differential display gel and this observation was confirmed w x by Northern analysis 26 .
Since the initial description of mRNA differential disw x play technique 4 , a number of modifications have been Ž . made on the primers: a a single base anchored primer w x was described 14 that required less primers to generate Ž . similar amplification results; b a primer with an extended restriction enzyme site was used to facilitate subcloning w x Ž . and direct sequencing of the PCR products 27 ; c longer Ž . primers 18-20 mers for RT and PCR, in combination Ž with two step PCR amplification the first several cycles done at low annealing temperatures and the subsequent cycles at higher annealing temperatures that improved the fidelity of the amplification and reduced the incidence of w x . false positive 15,16,22 . Additional modification has been made to overcome a strong bias towards high copy number w x mRNAs 23 , using selected primers that preferentially w x isolate mRNAs of moderate to low abundance 24 .
Band recoÕery and confirmation of the differentially expressed genes
Following mRNA differential display, the bands of interest may be recovered by applying the following steps: the DNA band is excised from the dried sequencing gel, isolated by extraction procedures, and reamplified using w x the same sets of primers as in the original PCR 4 . The recovered DNA band can serve as a probe to confirm mRNA expression by means of Northern blot analysis, andror be subcloned into a vector for further analysis.
Confirmation of gene expression is one of the critical steps following mRNA differential display, in as much as a large number of false positive bands may be present on differential display. A variety of methods have been utilized in different laboratories to reduce false positives, of which the most commonly used method is Northern blot analysis. In addition, dot blot, quantitative RTrPCR, ribonuclease protection assays and other methods have also been used.
Sequence analysis of the differentially expressed genes
Sequencing of the differentially expressed cDNA is a logical next step. This step relies on DNA sequencing analysis of the recovered DNA band. Because multiple DNA species may be present in this recovered band and the differential display primers are too small to be used successfully for direct sequencing using standard protocols, the differential displayed DNA fragments are typically subcloned into a vector prior to sequencing analysis w x 4,28 . Recent modifications using elongated primers for w x direct differential display 15,16 or the reamplification w x following the original differential display method 27 allow direct sequencing analysis of the PCR products if only a single DNA species is present in a particular band.
Based upon the sequence information, the identity of the differentially expressed genes can be determined by searching a computer database, such as GenBank. If it represents a novel gene, a cDNA library can be screened using this DNA probe in order to obtain the full length cDNA clone. It should also be noted that the cDNA fragments isolated by this method are in general small, and frequently X Ž . located in the 3 -untranslated region UTR . Therefore, in order to determine the identity of the differentially expressed gene, one may often require to isolate the full length cDNA clone
Functional analysis
The identification of the biological functions for the differentially expressed genes is one of the most challenging tasks. The gene may encode a secreted, cytoplasmic, or nuclear protein. To predict its function, one should first isolate the full length cDNA and predict the peptide sequence, and then explore the functional aspects based upon the encoding peptide. For example, the gene identified in Fig. 3B by differential display was further pursued for full length cloning and found to be a rat homologue of inter-Ž . feron inducible protein 10 IP-10 , a C-X-C chemokine w x 26 . Based upon structural and functional similarities of IP-10 to other cytokines and chemokines such as IL-1b Ž and IL-8 which have been demonstrated to involve SMC
. w x proliferation and migration 29,30 we hypothesized that IP-10 may have a role in vascular smooth muscle cell biology. IP-10 was then demonstrated to be a potent mitogen and chemotactic factor for vascular smooth muscle cells, two features of smooth muscle cell phenotypes that are believed to contribute to the pathogenesis of w x atherosclerosis and neointima formation 26 .
Applications of mRNA differential display in cardiovascular research
Despite the relative advantages and disadvantages of mRNA differential display, it has been demonstrated as a powerful tool for novel gene discovery and investigation of the mechanisms involved in many biological and pathological functions. A number of laboratories have successfully applied this technique in cardiovascular research, including in vitro and in vivo studies which are summarized in Table 3 .
Summary
mRNA differential display is one of the most flexible and comprehensive methods available for the detection of differentially expressed genes in cells and tissues. Since its initial description, this technique has been established in many laboratories and successfully applied for the identification of genes in in vitro and in vivo systems.
It also should be pointed out that similar to differential display, other methods, such as subtractive library screening, differential hybridization, electronic subtraction, SAGE and RDA, have also been successfully used for novel gene discovery. The application of these techniques will no doubt facilitate the discovery of novel therapeutic targets and help to understand the molecular mechanisms of disease. On the other hand, however, it should be pointed out that this is the first of many steps required in discovery of a novel therapeutic target especially as the function of the novel gene is likely to be unknown. Therefore, further actions should be taken to characterize the functions of the differentially expressed gene, including isolation of the full length cDNA, expression of the gene product for functional studies and target validation for the importance of this gene in disease processes. 
